Koen M. Marien

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses

Carlos Bais, Barbara M. Mueller, Mark F. Brady et al. · JNCI Journal of the National Cancer Institute · 2017 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue

Koen M. Marien, Valerie Croons, Yannick Waumans et al. · PLoS ONE · 2016 · 50 citations · Full text

Medicine, Oncology, Pathology +17

Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer

Marie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan et al. · Cancer Immunology Research · 2020 · 19 citations

Medicine, Immunology, Oncology +17

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer

Tim Muilwijk, Murat Akand, Sofie Daelemans et al. · PLoS ONE · 2021 · 15 citations · Full text

Medicine, Oncology, Urology +17

The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History

S. Mignon, Karen Willard‐Gallo, Gert Van den Eynden et al. · Pathology & Oncology Research · 2019 · 10 citations · Full text

Medicine, Immunology, Oncology +17